课题基金 / 基金详情

Studies on the functions of serine proteases and a novel-protein with low molecular size which are involved in the lectin complete pathway

Studies on the functions of serine proteases and a novel-protein with low molecular size which are involved in the lectin complete pathway
凝集素全通路丝氨酸蛋白酶和小分子新型蛋白的功能研究
批准号:
11670328
负责人:
MATSUSHITA Misao
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MATSUSHITA Misao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mannose-binding lectin (MBL) present in serum activates the complement system via the lectin pathway. Human MBL is associated with two types of Clr/Cls-like serine protease termed MASP and upon binding of MBL-MASP to carbohydrates, MASP cleaves C4, C2 and C3. MBL is also complexed with SMAP, a splicing variant of MASP-2. This study was aimed at elucidation of the activation mechanism of the lectin pathway in comparison with that of the classical pathway. Major achievements are as follows.1) MASP-1 and MASP-2 were isolated from human serum and successfully separated MASP-1 was copurified with sMAP. MASP-1 activated C3 and C2, while MASP-2 activated C4 and C2. Cl inhibitor which is a serum inhibitor of Clr and Cls also inhibited both MASP-1 and MASP-2. 2) MBL forms oligomers with different molecular sizes. Among them, MBL trimer preparations contained MASP-1 and SMAP, while MBL oligomers with higher molecular sizes contained MASP-2 and newly identified MASP-3. 3) In human serum, MBL and Clq were found to be complexed with MASP, sMAP and Clr.Cls, respectively. Neither MBL-Clr, Cls complex nor Clq-MASP, SMAP complex was present in human serum. 4) Like MBL, ficolin/P35 which is a human serum lectin was associated with MASP- 1, MASP-2 and SMAP. The complex activated the complement system, implying that complement activation by ficolin/P35-MASP as well as MBL-MASP can be considered to be termed as the lectin pathway.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
松下 操: "補体活性化機構"日本臨床. 57. 291-297 (1999)
Misao Matsushita:“补体激活机制”日本临床杂志 57. 291-297 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsushita, M.: "Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease"J.Immunol.. 164. 2281-2284 (2000)
Matsushita, M.:“ficolin 和甘露糖结合凝集素相关丝氨酸蛋白酶的补体激活复合物”J.Immunol.. 164. 2281-2284 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Matsushita: "Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease"J.Immunol. 164. 2281-2284 (2000)
M.Matsushita:“ficolin 和甘露糖结合凝集素相关丝氨酸蛋白酶的补体激活复合物”J.Immunol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    Clarification of the origin of the classical complement pathway
    • 批准号:
      17590442
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      MATSUSHITA Misao
    • 依托单位:
    A novel host defense mechanism mediated by a cornplex of host defense lectin and serine protease in innate immunity
    • 批准号:
      15590441
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2003
    • 负责人:
      MATSUSHITA Misao
    • 依托单位:
    Studies on a nocal sevine protease and the activation mechanism of the lectin complement pathway
    Elucidation of activation mechanism of the lectin complement pathway
    • 批准号:
      08670372
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1996
    • 负责人:
      MATSUSHITA Misao
    • 依托单位:
    国内基金
    海外基金
    Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      刘宇佳
    • 依托单位:
    足细胞中补体系统活化以及在足细胞损伤中作用机制研究
    • 批准号:
      81170657
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2011
    • 负责人:
      丁洁
    • 依托单位:
    抗单体C反应蛋白抗体在狼疮肾炎中参与补体调理与影响凋亡物质清除的机制研究
    • 批准号:
      81100497
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2011
    • 负责人:
      谭颖
    • 依托单位: